Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Shmuel Yaccoby

Concepts (361)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
72
2023
3049
5.260
 Why?
Osteoclasts
18
2015
428
2.660
 Why?
Bone Diseases
7
2014
95
2.220
 Why?
Gene Expression Regulation, Neoplastic
14
2018
858
1.680
 Why?
Osteoblasts
13
2012
475
1.420
 Why?
Neoplasm Proteins
7
2018
334
1.270
 Why?
Mice, SCID
23
2015
182
1.240
 Why?
Osteolysis
6
2013
75
1.210
 Why?
Boronic Acids
13
2013
183
1.190
 Why?
Coculture Techniques
12
2015
145
1.150
 Why?
Bone Marrow
10
2018
364
1.060
 Why?
Bone Marrow Cells
6
2015
190
0.990
 Why?
Bone Neoplasms
3
2014
184
0.960
 Why?
Cell Differentiation
14
2018
674
0.930
 Why?
Bone and Bones
9
2014
494
0.900
 Why?
Pyrazines
12
2013
190
0.900
 Why?
Mice
32
2015
5965
0.870
 Why?
Proteoglycans
6
2008
87
0.850
 Why?
Protein-Tyrosine Kinases
2
2014
89
0.830
 Why?
Cell Proliferation
11
2023
1029
0.770
 Why?
Neoplastic Stem Cells
2
2017
93
0.740
 Why?
Cell Communication
3
2015
72
0.730
 Why?
Intercellular Signaling Peptides and Proteins
4
2010
106
0.690
 Why?
Animals
35
2016
13523
0.680
 Why?
Osteogenesis
5
2012
366
0.670
 Why?
Membrane Glycoproteins
8
2009
244
0.660
 Why?
Bone Resorption
4
2011
302
0.650
 Why?
Cell Movement
6
2014
277
0.640
 Why?
Adipocytes
2
2018
130
0.620
 Why?
Insulin-Like Growth Factor Binding Protein 2
1
2018
10
0.610
 Why?
Humans
72
2023
52336
0.600
 Why?
Antineoplastic Agents
10
2015
1222
0.590
 Why?
Gene Expression
3
2018
623
0.560
 Why?
Gene Expression Regulation, Enzymologic
2
2017
181
0.540
 Why?
Gene Expression Profiling
9
2023
1110
0.530
 Why?
Thalidomide
8
2016
377
0.520
 Why?
Cell Survival
9
2015
602
0.510
 Why?
Protease Inhibitors
4
2010
61
0.510
 Why?
Tumor Microenvironment
2
2015
255
0.500
 Why?
Plasma Cells
8
2012
239
0.490
 Why?
Disease Models, Animal
8
2016
1484
0.470
 Why?
Cytokines
3
2015
625
0.470
 Why?
Cysteine-Rich Protein 61
1
2014
3
0.460
 Why?
Nicotinamide Phosphoribosyltransferase
1
2013
6
0.410
 Why?
Angiogenesis Inhibitors
3
2010
183
0.410
 Why?
Cell Line, Tumor
10
2015
1436
0.400
 Why?
Mesenchymal Stem Cell Transplantation
1
2012
19
0.390
 Why?
Rabbits
6
2013
374
0.390
 Why?
Parathyroid Hormone
4
2010
149
0.370
 Why?
Up-Regulation
3
2013
462
0.360
 Why?
Wnt Proteins
2
2010
102
0.360
 Why?
Signal Transduction
6
2013
1716
0.330
 Why?
Antineoplastic Combined Chemotherapy Protocols
9
2016
1031
0.320
 Why?
Transplantation, Heterologous
7
2009
79
0.320
 Why?
Receptor, EphB4
1
2009
5
0.320
 Why?
Ephrin-B2
1
2009
5
0.320
 Why?
Fenretinide
1
2009
5
0.320
 Why?
Dipeptidyl-Peptidases and Tripeptidyl-Peptidases
1
2009
6
0.320
 Why?
Models, Biological
4
2010
743
0.320
 Why?
Placenta
1
2011
154
0.310
 Why?
Dipeptides
1
2009
21
0.310
 Why?
Disease Progression
8
2014
870
0.310
 Why?
Cell Adhesion Molecules
1
2009
87
0.300
 Why?
Bone Development
1
2009
66
0.290
 Why?
Tumor Necrosis Factor Ligand Superfamily Member 13
1
2007
3
0.290
 Why?
Transmembrane Activator and CAML Interactor Protein
1
2007
6
0.290
 Why?
Extracellular Matrix Proteins
1
2008
69
0.290
 Why?
Apoptosis
8
2012
1127
0.280
 Why?
Bone Remodeling
4
2012
154
0.270
 Why?
Prognosis
12
2018
2094
0.270
 Why?
Recombinant Fusion Proteins
1
2007
179
0.270
 Why?
Melphalan
3
2016
181
0.260
 Why?
Tumor Cells, Cultured
8
2013
456
0.260
 Why?
Immunohistochemistry
5
2015
985
0.250
 Why?
Antibodies
1
2006
152
0.250
 Why?
Neoplasm Recurrence, Local
3
2023
643
0.250
 Why?
Serine Endopeptidases
1
2006
50
0.250
 Why?
Cell Division
6
2004
291
0.250
 Why?
RNA, Small Interfering
4
2013
218
0.250
 Why?
Antigens, Neoplasm
1
2006
147
0.240
 Why?
Severe Combined Immunodeficiency
1
2005
11
0.230
 Why?
Neovascularization, Pathologic
4
2009
158
0.230
 Why?
Flow Cytometry
6
2015
404
0.230
 Why?
Alkaline Phosphatase
6
2017
94
0.230
 Why?
Syndecan-1
6
2007
73
0.230
 Why?
NF-kappa B
4
2013
328
0.220
 Why?
Hematopoietic Stem Cells
3
2012
188
0.220
 Why?
Receptors, CXCR4
2
2014
29
0.220
 Why?
Gene Knockdown Techniques
2
2014
110
0.210
 Why?
Bone Density
3
2010
399
0.200
 Why?
Translocation, Genetic
2
2021
265
0.200
 Why?
Positron-Emission Tomography
2
2017
303
0.200
 Why?
Killer Cells, Natural
2
2015
116
0.200
 Why?
Stromal Cells
1
2003
77
0.200
 Why?
Transcription Factors
2
2023
574
0.200
 Why?
Female
21
2018
28105
0.190
 Why?
Neoplasm Transplantation
3
2014
87
0.190
 Why?
Immunophenotyping
2
2015
117
0.190
 Why?
T-Lymphocytes
2
2015
340
0.180
 Why?
Cell Line
2
2015
1045
0.180
 Why?
Immunotherapy, Adoptive
2
2015
167
0.180
 Why?
Immunoglobulin Light Chains
2
2015
90
0.180
 Why?
Epigenomics
1
2021
75
0.180
 Why?
Antibodies, Monoclonal
4
2016
481
0.170
 Why?
Bone Transplantation
4
2010
42
0.170
 Why?
Decorin
2
2012
7
0.170
 Why?
Oligonucleotide Array Sequence Analysis
4
2015
412
0.170
 Why?
Cells, Cultured
4
2013
1589
0.160
 Why?
Neoplasm Metastasis
2
2014
240
0.160
 Why?
Syndecans
5
2006
37
0.160
 Why?
Drug Resistance, Neoplasm
2
2015
327
0.160
 Why?
Genes, myc
1
2019
39
0.160
 Why?
Cell Adhesion
2
2014
164
0.150
 Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2015
583
0.150
 Why?
Mice, Transgenic
4
2007
563
0.140
 Why?
Male
17
2018
26696
0.140
 Why?
Risk Factors
5
2018
3872
0.140
 Why?
Cyclin-Dependent Kinases
2
2015
26
0.140
 Why?
Hexokinase
1
2017
16
0.140
 Why?
Diffusion Magnetic Resonance Imaging
1
2018
133
0.140
 Why?
Chromosomes, Human, Pair 17
1
2017
35
0.140
 Why?
Monoclonal Gammopathy of Undetermined Significance
2
2018
125
0.140
 Why?
Chromosome Aberrations
3
2016
297
0.130
 Why?
Calcification, Physiologic
1
2017
42
0.130
 Why?
Tumor Suppressor Protein p53
2
2017
224
0.130
 Why?
Disease-Free Survival
5
2018
460
0.130
 Why?
Proteasome Inhibitors
2
2016
105
0.130
 Why?
Pelvis
1
2017
69
0.130
 Why?
Stem Cells
2
2009
182
0.130
 Why?
Chromosome Deletion
1
2017
142
0.130
 Why?
Biopsy
2
2018
604
0.130
 Why?
Neoplasm, Residual
1
2017
173
0.130
 Why?
Neoplasms, Experimental
2
2007
113
0.130
 Why?
Recurrence
3
2014
672
0.130
 Why?
Pyridinium Compounds
1
2015
20
0.120
 Why?
Base Sequence
2
2008
648
0.120
 Why?
Fluorodeoxyglucose F18
1
2017
188
0.120
 Why?
Homologous Recombination
1
2015
41
0.120
 Why?
Benzimidazoles
1
2015
50
0.120
 Why?
Endothelial Cells
2
2009
283
0.120
 Why?
Xenograft Model Antitumor Assays
3
2015
222
0.120
 Why?
Peptide Nucleic Acids
1
2015
18
0.120
 Why?
Rad51 Recombinase
1
2015
25
0.120
 Why?
Genes, Neoplasm
1
2015
31
0.120
 Why?
Bromodeoxyuridine
2
2005
19
0.120
 Why?
Aged
11
2017
10109
0.120
 Why?
Immunologic Factors
1
2016
117
0.120
 Why?
Time Factors
7
2017
2957
0.120
 Why?
Genomic Instability
1
2015
89
0.120
 Why?
Diphosphonates
2
2008
92
0.110
 Why?
Antigens, CD
1
2015
219
0.110
 Why?
Asymptomatic Diseases
1
2014
38
0.110
 Why?
Carrier Proteins
4
2008
326
0.110
 Why?
Proteome
1
2015
170
0.110
 Why?
Immunotherapy
1
2016
244
0.110
 Why?
Interleukin-6
2
2005
278
0.100
 Why?
Nicotinamide Mononucleotide
1
2013
4
0.100
 Why?
Acrylamides
1
2013
8
0.100
 Why?
Antigens, CD19
2
2005
28
0.100
 Why?
Poly(ADP-ribose) Polymerases
1
2013
30
0.100
 Why?
Niacinamide
1
2013
24
0.100
 Why?
Enzyme Induction
1
2013
77
0.100
 Why?
NAD
1
2013
45
0.100
 Why?
Amides
1
2013
37
0.100
 Why?
Nitriles
1
2013
53
0.100
 Why?
Sirtuin 1
1
2013
29
0.100
 Why?
Enzyme Inhibitors
2
2013
374
0.100
 Why?
Chemokine CXCL12
1
2013
34
0.100
 Why?
Proteomics
1
2015
326
0.100
 Why?
beta Catenin
1
2013
103
0.100
 Why?
Oligopeptides
1
2013
93
0.100
 Why?
Tumor Burden
2
2010
136
0.100
 Why?
Middle Aged
11
2018
13014
0.100
 Why?
Leukemia
1
2013
67
0.100
 Why?
Magnetic Resonance Imaging
2
2012
1543
0.100
 Why?
Myelodysplastic Syndromes
1
2013
86
0.100
 Why?
Injections, Intravenous
1
2012
135
0.100
 Why?
Proto-Oncogene Proteins c-jun
2
2009
76
0.100
 Why?
Piperidines
1
2013
97
0.100
 Why?
Myeloma Proteins
2
2004
26
0.100
 Why?
Cytotoxicity, Immunologic
1
2012
58
0.100
 Why?
Remission Induction
1
2012
218
0.090
 Why?
Neoplasm Staging
3
2015
770
0.090
 Why?
RNA, Messenger
3
2015
1142
0.090
 Why?
Anti-Inflammatory Agents
1
2012
166
0.090
 Why?
Renal Insufficiency
1
2012
113
0.090
 Why?
Glycoproteins
2
2001
123
0.090
 Why?
Lymph Nodes
1
2012
252
0.080
 Why?
beta 2-Microglobulin
2
2007
39
0.080
 Why?
JNK Mitogen-Activated Protein Kinases
2
2007
72
0.080
 Why?
Early Growth Response Protein 1
1
2009
34
0.080
 Why?
Dexamethasone
3
2007
440
0.080
 Why?
Myocardium
1
2012
480
0.080
 Why?
Sphingosine
1
2009
34
0.080
 Why?
Organoids
1
2009
39
0.080
 Why?
Drug Screening Assays, Antitumor
1
2009
136
0.080
 Why?
Prospective Studies
5
2016
2428
0.080
 Why?
Caspases
1
2009
105
0.080
 Why?
Lysophospholipids
1
2009
70
0.080
 Why?
p38 Mitogen-Activated Protein Kinases
1
2009
95
0.080
 Why?
Leukocytes, Mononuclear
1
2009
122
0.080
 Why?
Enzyme Activation
1
2009
272
0.080
 Why?
Glucuronidase
2
2007
47
0.070
 Why?
Lentivirus
1
2008
17
0.070
 Why?
Wnt3 Protein
1
2008
7
0.070
 Why?
Ellipticines
1
2008
2
0.070
 Why?
Wnt3A Protein
1
2008
12
0.070
 Why?
Bone Density Conservation Agents
1
2009
75
0.070
 Why?
Cyclin-Dependent Kinase Inhibitor p21
1
2008
68
0.070
 Why?
B-Cell Activating Factor
1
2007
3
0.070
 Why?
Precancerous Conditions
1
2008
85
0.070
 Why?
Cytological Techniques
1
2007
13
0.070
 Why?
Diploidy
1
2007
25
0.070
 Why?
Genetic Vectors
1
2008
128
0.070
 Why?
Phosphorylation
1
2009
531
0.070
 Why?
RNA Interference
1
2008
186
0.070
 Why?
Karyotyping
1
2007
78
0.070
 Why?
Heparan Sulfate Proteoglycans
1
2007
12
0.070
 Why?
Kidney
1
2012
708
0.070
 Why?
Receptor Activator of Nuclear Factor-kappa B
2
2004
33
0.070
 Why?
Hematopoietic Stem Cell Transplantation
1
2012
606
0.070
 Why?
Reactive Oxygen Species
1
2009
425
0.070
 Why?
Mice, Inbred C57BL
1
2012
1903
0.070
 Why?
Models, Animal
1
2007
228
0.070
 Why?
Phenotype
2
2009
799
0.070
 Why?
Treatment Outcome
6
2017
5407
0.060
 Why?
Immunosuppressive Agents
1
2008
243
0.060
 Why?
Gelatinases
1
2006
32
0.060
 Why?
Risk Assessment
3
2018
1323
0.060
 Why?
Endopeptidases
1
2006
66
0.060
 Why?
Survival Analysis
2
2018
671
0.060
 Why?
Antigens, CD34
1
2005
73
0.060
 Why?
RANK Ligand
2
2004
187
0.060
 Why?
Adult
6
2018
14139
0.060
 Why?
Fetal Tissue Transplantation
1
2005
12
0.060
 Why?
Hematologic Neoplasms
1
2006
106
0.060
 Why?
Metaphase
2
2016
46
0.060
 Why?
Molecular Sequence Data
1
2006
792
0.060
 Why?
Annexin A5
1
2004
14
0.060
 Why?
Endothelium, Vascular
1
2006
261
0.060
 Why?
Culture Media, Conditioned
1
2004
47
0.060
 Why?
Survival Rate
2
2018
940
0.050
 Why?
Phagocytosis
1
2004
51
0.050
 Why?
Clinical Trials as Topic
3
2016
468
0.050
 Why?
Membrane Proteins
1
2006
340
0.050
 Why?
Polymerase Chain Reaction
1
2005
460
0.050
 Why?
Pregnancy
1
2011
2675
0.050
 Why?
Endothelial Growth Factors
1
2002
10
0.050
 Why?
Vascular Endothelial Growth Factors
1
2002
14
0.050
 Why?
Lymphokines
1
2002
20
0.050
 Why?
Biotransformation
1
2002
85
0.050
 Why?
Blotting, Western
2
2015
596
0.050
 Why?
Oxidative Stress
1
2007
810
0.050
 Why?
Oncogenes
1
2021
60
0.050
 Why?
Vascular Endothelial Growth Factor A
1
2002
186
0.050
 Why?
Combined Modality Therapy
2
2016
636
0.050
 Why?
Imidazoles
1
2002
124
0.040
 Why?
Polycomb Repressive Complex 2
1
2021
48
0.040
 Why?
Chromatin
1
2021
141
0.040
 Why?
Cell Polarity
1
2000
17
0.040
 Why?
Liver Transplantation
1
2002
165
0.040
 Why?
Cell Transplantation
1
1999
3
0.040
 Why?
Mice, Inbred ICR
1
1999
25
0.040
 Why?
Histones
1
2021
316
0.040
 Why?
Cell Membrane
1
2000
245
0.040
 Why?
Protein Disulfide-Isomerases
1
2019
14
0.040
 Why?
Genes, Immunoglobulin Heavy Chain
1
2019
13
0.040
 Why?
Dose-Response Relationship, Drug
2
2016
1377
0.040
 Why?
Osteoprotegerin
3
2006
53
0.040
 Why?
Radiation Chimera
1
1998
4
0.040
 Why?
Multivariate Analysis
2
2012
590
0.040
 Why?
Clone Cells
1
1998
77
0.040
 Why?
Radiography
2
2012
470
0.040
 Why?
Aged, 80 and over
2
2017
3391
0.040
 Why?
In Situ Hybridization, Fluorescence
1
2019
263
0.040
 Why?
DNA-Binding Proteins
1
2021
429
0.040
 Why?
Tomography, X-Ray Computed
2
2017
1162
0.030
 Why?
False Positive Reactions
1
2017
63
0.030
 Why?
Liver
1
2002
1159
0.030
 Why?
Indolizines
1
2015
5
0.030
 Why?
Imaging, Three-Dimensional
1
2017
150
0.030
 Why?
Cyclic N-Oxides
1
2015
12
0.030
 Why?
Drug Synergism
1
2015
148
0.030
 Why?
S Phase
1
2015
19
0.030
 Why?
Genes, BRCA1
1
2015
19
0.030
 Why?
Transcriptome
1
2018
367
0.030
 Why?
Follow-Up Studies
2
2013
2268
0.030
 Why?
Real-Time Polymerase Chain Reaction
1
2015
186
0.030
 Why?
Predictive Value of Tests
2
2007
943
0.030
 Why?
Enzyme-Linked Immunosorbent Assay
1
2015
236
0.030
 Why?
Transcription, Genetic
1
2015
385
0.030
 Why?
DNA Damage
1
2015
307
0.030
 Why?
Transfection
2
2004
372
0.020
 Why?
Interleukin Receptor Common gamma Subunit
1
2012
8
0.020
 Why?
NK Cell Lectin-Like Receptor Subfamily K
1
2012
9
0.020
 Why?
Acute Disease
1
2013
374
0.020
 Why?
Interleukin-2
1
2012
69
0.020
 Why?
Mice, Inbred NOD
1
2012
92
0.020
 Why?
Immunoenzyme Techniques
1
2012
137
0.020
 Why?
Creatinine
1
2012
149
0.020
 Why?
Glomerular Filtration Rate
1
2012
124
0.020
 Why?
Lymphocyte Activation
1
2012
172
0.020
 Why?
Receptors, Tumor Necrosis Factor
2
2001
39
0.020
 Why?
C-Reactive Protein
1
2012
155
0.020
 Why?
Receptors, Cytoplasmic and Nuclear
2
2001
67
0.020
 Why?
Proportional Hazards Models
1
2012
443
0.020
 Why?
Radiation-Sensitizing Agents
1
2010
52
0.020
 Why?
Inhibitor of Apoptosis Proteins
1
2009
21
0.020
 Why?
Antibody-Dependent Cell Cytotoxicity
1
2009
12
0.020
 Why?
Incidence
1
2013
1059
0.020
 Why?
Protein Transport
1
2010
183
0.020
 Why?
Microtubule-Associated Proteins
1
2009
65
0.020
 Why?
Peptides
1
2010
229
0.020
 Why?
Down-Regulation
1
2009
347
0.020
 Why?
CDC2-CDC28 Kinases
1
2008
11
0.020
 Why?
Salvage Therapy
1
2008
136
0.020
 Why?
Protein Binding
1
2009
680
0.020
 Why?
Antibodies, Monoclonal, Humanized
1
2009
236
0.020
 Why?
Proteins
1
2010
354
0.020
 Why?
Antineoplastic Agents, Hormonal
1
2007
53
0.020
 Why?
Cytogenetic Analysis
1
2007
80
0.020
 Why?
Phospholipase C gamma
1
2006
4
0.020
 Why?
Caspase 9
1
2006
13
0.020
 Why?
Chi-Square Distribution
1
2007
288
0.020
 Why?
Cell Cycle
1
2008
240
0.020
 Why?
Retrospective Studies
2
2012
6578
0.020
 Why?
Mitogen-Activated Protein Kinase 3
1
2006
49
0.020
 Why?
Bone Marrow Transplantation
1
2007
113
0.020
 Why?
Cyclin D
1
2006
18
0.020
 Why?
src-Family Kinases
1
2006
34
0.020
 Why?
Cyclins
1
2006
38
0.020
 Why?
RNA, Neoplasm
1
2006
45
0.020
 Why?
Case-Control Studies
1
2009
1201
0.020
 Why?
Chromosome Mapping
1
2006
155
0.020
 Why?
Mice, Inbred BALB C
1
2006
312
0.020
 Why?
Proto-Oncogene Proteins c-akt
1
2006
172
0.020
 Why?
Cluster Analysis
1
2006
232
0.020
 Why?
Phosphatidylinositol 3-Kinases
1
2006
150
0.020
 Why?
Kaplan-Meier Estimate
1
2007
484
0.020
 Why?
Data Interpretation, Statistical
1
2006
164
0.020
 Why?
Transplantation, Autologous
1
2007
488
0.010
 Why?
Logistic Models
1
2007
920
0.010
 Why?
DNA, Complementary
1
2004
137
0.010
 Why?
Young Adult
1
2013
4319
0.010
 Why?
Recombinant Proteins
1
2004
491
0.010
 Why?
Randomized Controlled Trials as Topic
1
2005
594
0.010
 Why?
Solubility
1
2002
80
0.010
 Why?
Leukemia, Plasma Cell
1
2002
33
0.010
 Why?
Acid Phosphatase
1
2001
12
0.010
 Why?
Protein Structure, Tertiary
1
2002
252
0.010
 Why?
Adolescent
1
2013
6692
0.010
 Why?
Neoplasm Invasiveness
1
2002
278
0.010
 Why?
Leukemia, Lymphocytic, Chronic, B-Cell
1
2001
59
0.010
 Why?
Hodgkin Disease
1
2001
49
0.010
 Why?
Isoenzymes
1
2001
167
0.010
 Why?
Reference Values
1
2001
313
0.010
 Why?
Paraproteinemias
1
2001
74
0.010
 Why?
LDL-Receptor Related Protein-Associated Protein
1
2000
1
0.010
 Why?
Hepatocyte Growth Factor
1
2000
11
0.010
 Why?
Intercellular Adhesion Molecule-1
1
2000
62
0.010
 Why?
Epithelial Cells
1
2000
215
0.010
 Why?
Yaccoby's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (361) concept(s)
_
Co-Authors Expand Description
See all (28) people
_
Similar People Expand Description
See all (35) people
_
Same Department Expand Description
Search Department